Introduction
Signal transducers and activators of transcription (Stat) 1 proteins are mediators of transcription of several cytokine-inducible genes. These proteins exist as latent cytoplasmic monomers until cytokine stimulation, whereupon they are phosphorylated by the Janus family of kinases (JAKs), dimerize, and translocate to the nucleus. Once in the nucleus, activated Stats bind specific canonical DNA elements and initiate cytokine-specific gene transcription (1) . To date, six Stat proteins have been described (2) and of these, only Stat6 has been shown to be specifically activated by IL-4 and IL-13 (3) (4) (5) (6) .
It is clear from the characterization of Stat6-deficient mice that Stat6 is required for IL-4-and IL-13-dependent gene induction. Stat6-/-mice are deficient in their ability to mount a Th2 response following nematode infection, fail to produce IgE, and do not develop airway hypersensitivity following antigen challenge (3) (4) (5) (6) (7) (8) (9) . The importance of Stat6 in human allergic disease is supported by the fact that Stat6 expression is increased in the bronchial epithelium of humans with severe asthma (10) and that polymorphic variants of Stat6 have been reported to associate with atopic asthma (11). SOCS proteins form a negative feedback loop whereby SOCS genes are induced following cytokine stimulation and, once produced, inhibit cytokine signaling (16, 17) . SOCS-1 has been
shown to bind and inhibit JAK kinases, but this may not be true of all SOCS family members. A number of PIAS proteins have recently been described (18, 19) , which bind specifically to phosphorylated Stat dimers and prevent them from binding DNA (20) . Recently, arginine methylation was shown to be another mechanism by which Stats can be regulated (21) .
Methylation of Stat1 prevented its association with PIAS1, thereby increasing the amount of 
Electrophoretic Mobility Shift Assay (EMSA)
Cells (2.5 x 10 6 ) were stimulated with IL-4 (10 ng/ml) for 15 minutes, pelleted by centrifugation at 10,000 ¥ g and reconstituted in lysis buffer (10 mM Hepes pH 7.9, 10 mM KCl, 0.1 mM EDTA, 1.5 mM MgCl 2 , 0.2% NP-40, 1.0 mM DTT, 0.5 mM PMSF). Lysates were centrifuged at 10,000 ¥ g for 5 minutes at 4!C and supernatants containing the cytoplasmic extracts were removed. Pelleted nuclei were reconstituted in nuclear extract buffer (20 mM Hepes pH 7.9, 420 mM NaCl, 0.1 mM EDTA, 1.5 mM MgCl 2 , 25% glycerol, 1.0 mM DTT, 0.5 mM PMSF). EMSA were performed as previously described (22, 23) . For the detergent treated samples, cytoplasmic and nuclear extracts were prepared for EMSA as described above. Ten percent deoxycholic acid (DOC) (Sigma) was added to achieve the noted final concentration and the samples were incubated on ice for 15 minutes. Radiolabeled Stat6 probe and nonionic detergent Igepal CA-630 (Sigma) were then added, to a final concentration of 1.2% Igepal.
Samples prepared without DOC were incubated with the radiolabeled Stat6 probe only. Samples were incubated on ice for 15 minutes and then resolved by polyacryamide gel electrophoresis as previously described (22, 23) Immunoprecipitation and immunoblotting A201.1 cells (2 ¥ 10 7 ) were pelleted by centrifugation at 20,000 ¥ g at 4!C and Stat6 was 
Cytoplasmic extracts do not inhibit Stat6 DNA binding activity
Our data established that although phosphorylated Stat6 was present in the cytoplasm, it was unable to bind cognate DNA sequences. One possibility for this was that cytoplasmic extracts contained an inhibitor capable of interfering with the DNA binding activity of phosphorylated Stat6. In order to address this, we examined the ability of cytoplasmic extracts to inhibit the Stat6 DNA binding present in nuclear extracts (Figure 3 ). Increasing amounts of cytoplasmic extracts were added to nuclear extracts of activated A201.1 cells and then the mixtures were assayed for DNA binding activity. As expected, DNA binding activity was present in the nuclear extracts, but not the cytoplasmic extracts. Addition of cytoplasmic extracts to the nuclear extracts had no effect on the DNA binding activity of the nuclear extracts even at a 10-fold excess of cytoplasmic extracts. Thus, cytoplasmic extracts do not contain a transferable inhibitor of Stat6 DNA binding activity. Since DNA binding activity was restored in detergent-treated cytoplasmic extracts, we reasoned that the inhibitor might be unbound in these extracts. Thus, we investigated whether detergent-treated cytoplasmic extracts could inhibit nuclear DNA binding activity. We utilized varying ratios of the cytoplasmic:nuclear extracts prepared from A201.1 cells, and even with a
Detergent treatment unmasks cytoplasmic

Discussion
Cytokine signaling involves many steps: the production of cytokine, the expression of its receptor, the recruitment of kinases, the activation of transcription factors followed by their translocation to the nucleus and binding to cognate DNA sequences. Each one of these layers of activation provides the potential for regulation. Herein, we describe the first report of a detergent-sensitive factor that blocks the DNA binding activity of activated Alternatively, the factor may act as a chaperone protein, which may be required for the nuclear localization of Stat6. The nuclear import requirements for Stat6 remain to be identified.
Importin proteins have been shown to be involved in the nuclear localization of Stat1.
Interestingly, in addition its role in nuclear localization, importin a5 has been reported to competitively block the Stat1 DNA binding site (24). Nuclear localization occurs both at the level of nuclear import and nuclear export (25) . Although a leucine-rich nuclear export signal
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(NES) has recently been implicated in the nuclear localization of Stat1 (26) by guest on January 21, 2018
